Skip to main content
Advertisement
Advertisement
WST
WST logo
West Pharmaceutical Services, Inc.
412.62
USD
Sponsored
-4.05
-0.97%
Oct 30, 15:00 UTC -5
Closed
exchange

After-Market

412.81

+0.19
+0.04%

West Pharmaceutical Services, Inc. (WST) Earnings

WST Earnings Reports

Positive Surprise Ratio

WST beat 38 of 43 last estimates.

88%

Next Report

Date of Next Report
Feb 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$835.00M
/
$2.29
Implied change from Q3 26 (Revenue/ EPS)
-4.52%
/
-13.91%
Implied change from Q4 25 (Revenue/ EPS)
+3.73%
/
+12.25%

West Pharmaceutical Services, Inc. earnings per share and revenue

On Oct 29, 2026, WST reported earnings of 2.66 USD per share (EPS) for Q3 26, beating the estimate of 2.21 USD, resulting in a 20.21% surprise. Revenue reached 874.50 million, compared to an expected 833.96 million, with a 4.86% difference. The market reacted with a +3.23% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 2.29 USD, with revenue projected to reach 835.00 million USD, implying an decrease of -13.91% EPS, and decrease of -4.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Align Technology Inc
Report Date
Oct 28, 2026 For Q3 26
Estimate
$2.83
Actual
$2.80
Surprise
-1.11%
logo
Merit Medical Systems Inc
Report Date
Oct 29, 2026 For Q3 26
Estimate
$1.05
Actual
$1.12
Surprise
+6.09%
logo
CONMED Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$1.02
Actual
$1.04
Surprise
+1.67%
logo
Pro-Dex Inc New
Report Date
Oct 29, 2026 For Q1 27
Estimate
$0.68
Actual
$0.92
Surprise
+34.62%
FAQ
For Q3 2026, West Pharmaceutical Services, Inc. reported EPS of $2.66, beating estimates by 20.21%, and revenue of $874.50M, 4.86% above expectations.
The stock price moved up 3.23%, changed from $403.64 before the earnings release to $416.67 the day after.
The next earning report is scheduled for Feb 10, 2027.
Based on -- analysts, West Pharmaceutical Services, Inc. is expected to report EPS of $2.29 and revenue of $835.00M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement